Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-Blind Controlled Phase III Trial of Hyperbaric Oxygen Therapy in Patients Suffering Long-Term Adverse Effects of Radiotherapy for Pelvic Cancer (HOT II)

NCT01087268 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT01087268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01087268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-Blind Controlled Phase III Trial of Hyperbaric Oxygen Therapy in Patients Suffering Long-Term Adverse Effects of Radiotherapy for Pelvic Cancer (HOT II)
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2009
Completion date
Not reported
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, cervical cancer, colorectal cancer, endometrial cancer, gastrointestinal complications, long-term effects secondary to cancer therapy in adults, ovarian cancer, prostate cancer, radiation toxicity, sarcoma, testicular germ cell tumor, vaginal cancer